Chronic Idiopathic Constipation News and Research

RSS
Chronic Idiopathic Constipation (CIC) is defined as the chronic presence of constipation symptoms. It is called idiopathic because the cause of this type of constipation is unknown and it is not caused by underlying illness or medication.
Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Swissmedic grants marketing authorization for Amitiza

Swissmedic grants marketing authorization for Amitiza

Albireo completes A3309 phase 1b study in patients with chronic idiopathic constipation

Albireo completes A3309 phase 1b study in patients with chronic idiopathic constipation

European MAA for lubiprostone withdrawn by Sucampo Pharma Europe

European MAA for lubiprostone withdrawn by Sucampo Pharma Europe

Sucampo Pharmaceuticals initiates phase 3 trial of Lubiprostone for chronic idiopathic constipation in Japan

Sucampo Pharmaceuticals initiates phase 3 trial of Lubiprostone for chronic idiopathic constipation in Japan

Lubiprostone brings relief for many IBS patients who experience constipation

Lubiprostone brings relief for many IBS patients who experience constipation

FDA approves Amitiza for irritable bowel syndrome with constipation

FDA approves Amitiza for irritable bowel syndrome with constipation

FDA accepts Sucampo's sNDA for Lubiprostone for the treatment of irritable bowel syndrome

FDA accepts Sucampo's sNDA for Lubiprostone for the treatment of irritable bowel syndrome

NDA for Lubiprostone to treat irritable bowel syndrome with constipation

NDA for Lubiprostone to treat irritable bowel syndrome with constipation

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome